VIENNA — Some patients who had mild COVID-19 infection during the first wave of the pandemic and continued to experience postinfection symptoms for at least 12 months after infection present abnormal ...
Please provide your email address to receive an email when new articles are posted on . The FDA has announced premarket approval of a new device that can temporarily ventilate, oxygenate and perfuse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback